Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors as an off-label treatment for chronic pain.

In 2009, the late Spaceman took GW inside the inner workings of rock’s makeup-clad warriors – like that time he forged ahead ...

The edits were easy to miss: The description on the front of the Mr. Goodbar wrapper changed from “milk chocolate with ...

Limited to an edition of 60, the “King Alphonso” screenprints will be available exclusively via Pace Prints starting November ...

See how total commerce and total experience work, the stack to buy, a 90-day pilot plan, and the KPIs that prove ROI, without ...

When Pierre Poilievre spoke about accountability and corruption, the media swarmed like bees to sugar. Headlines screamed ...

With its standout deals and generous employment practices, the warehouse chain became a feel-good American institution. In a fraught time, it can be hard to remain beloved.

Former Dread Central editor-in-chief Steve Barton on feeling unduly cut out from the killer clown franchise by Damien Leone and Phil Falcone.

How four PSPs found growth, stickier client relationships, and opportunity in diversifying beyond their core businesses.

India's food regulator issued a ban on using 'ORS' label for sugary drinks after an eight-year campaign by a Hyderabad paediatrician. Dr. Sivaranjani Santosh calls it a "people's win." ...